These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1261754)

  • 1. [Chemical fractionation of Brucella melitensis and the immunizing properties of a new fraction].
    Roux J; Serre A; Bascoul S; Lacave C; Lopez A
    Dev Biol Stand; 1976; 31():92-9. PubMed ID: 1261754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Structure and constituents of Brucella. Characterization and biological properties of the fractions].
    Dubray G; Plommet M
    Dev Biol Stand; 1976; 31():68-91. PubMed ID: 1261752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological properties and chemical composition of a soluble fraction of Brucella abortus. Monospecific A or M antigens].
    Renoux G; Renoux M; Guillaumin JM
    Dev Biol Stand; 1976; 31():100-9. PubMed ID: 816680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization by an insoluble fraction extracted from Brucella melitensis: immunological and chemical characterization of the active substances.
    Lopez-Merino A; Asselineau J; Serre A; Roux J; Bascoul S; Lacave C
    Infect Immun; 1976 Feb; 13(2):311-21. PubMed ID: 770324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological properties of a phenol-insoluble extract from Brucella melitensis (P.I. fraction)].
    Roux J; Asselineau J; Serre A; Lacave C
    Ann Inst Pasteur (Paris); 1967 Sep; 113(3):411-23. PubMed ID: 6048204
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the genetic control of murine humoral response to immunization with a peptidoglycan-containing fraction extracted from Brucella melitensis.
    Cannat A; Feingold N; Caffin JC; Serre A
    Ann Immunol (Paris); 1979; 130C(5):675-85. PubMed ID: 118703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulating activity of Brucella fractions in a human lymphocyte transformation test. Correlation with humoral and cellular immunity.
    Bascoul S; Peraldi M; Merino AL; Lacave C; Cannat A; Serre A
    Immunology; 1976 Nov; 31(5):717-22. PubMed ID: 992708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism between two immunogens extracted from Brucella (cell wall peptidoglycan and lipopolysaccharide fractions) and inactivity of the brucellin allergen in immunization of the mouse.
    Bosseray N; Plommet M
    Ann Microbiol (Paris); 1980; 131A(2):157-69. PubMed ID: 7387055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lymphoblastic transformation by fractions of Brucella in patients having had brucellosis and subjects vaccinated by the vaccine PI].
    Peraldi M; Lopez A; Lacave C; Bascoul S; Serre A
    Dev Biol Stand; 1976; 31():157-64. PubMed ID: 1261734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative analysis of antigens from different Brucella species using immunoblotting with antisera from immunized rabbits].
    Kulakov IuK; Zheludkov MM; Lavrova VA; Dranovskaia EA; Skavronskaia AG
    Mol Gen Mikrobiol Virusol; 1998; (2):7-13. PubMed ID: 9611754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical identification of antigens of Brucella melitensis by means of CRIE.
    Geraci D; Locorotondo G; Parlato A; Cocchiara R; Caracappa S; Aiello P; Guercio V; Scarlata F; Cascio G
    Microbiologica; 1987 Apr; 10(2):161-9. PubMed ID: 3587065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice.
    Estevan M; Gamazo C; Grilló MJ; Del Barrio GG; Blasco JM; Irache JM
    Vaccine; 2006 May; 24(19):4179-87. PubMed ID: 16481077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-linked immunosorbent assay for Brucella melitensis-associated antigens.
    Geraci D; Locorotondo G; Parlato A; Cocchiara R; Caracappa S; Scarlata F; Cascio A
    Microbiologica; 1988 Jul; 11(3):213-8. PubMed ID: 3173124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on Brucella-L-forms. II. Serological properties of Brucella-L-forms].
    Peschkov J
    Zentralbl Bakteriol Orig A; 1971 Dec; 218(4):437-43. PubMed ID: 4400725
    [No Abstract]   [Full Text] [Related]  

  • 17. [Somatic antigens of the Brucella genus. The structure of the O-specific polysaccharide chain of Brucella melitensis lipopolysaccharide].
    L'vov VL; Malikov VE; Shashkov AS; Dranovskaia EA; Dmitriev BA
    Bioorg Khim; 1985 Jul; 11(7):963-9. PubMed ID: 2413867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
    Bolpe J; de Lapenta DF; García-Carrillo C
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of immunological properties of 2 lipopolysaccharide fractions and of 1 polysaccharide fraction isolated from Brucella melitensis].
    Serre A; Asselineau J; Lacave C; Bascoul S
    Ann Inst Pasteur (Paris); 1971 Oct; 121(4):479-91. PubMed ID: 4111139
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.